Cargando…

eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells

The nitric oxide (NO) secreted by vascular endothelium is required for the maintenance of cardiovascular homeostasis. Diminished release of NO generated by endothelial NO synthase contributes to endothelial dysfunction. Hypoxia and ischemia reduce endothelial eNOS expression via posttranscriptional...

Descripción completa

Detalles Bibliográficos
Autores principales: Janaszak-Jasiecka, Anna, Siekierzycka, Anna, Bartoszewska, Sylwia, Serocki, Marcin, Dobrucki, Lawrence W., Collawn, James F., Kalinowski, Leszek, Bartoszewski, Rafal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208887/
https://www.ncbi.nlm.nih.gov/pubmed/29737439
http://dx.doi.org/10.1007/s10456-018-9620-y
_version_ 1783366800933650432
author Janaszak-Jasiecka, Anna
Siekierzycka, Anna
Bartoszewska, Sylwia
Serocki, Marcin
Dobrucki, Lawrence W.
Collawn, James F.
Kalinowski, Leszek
Bartoszewski, Rafal
author_facet Janaszak-Jasiecka, Anna
Siekierzycka, Anna
Bartoszewska, Sylwia
Serocki, Marcin
Dobrucki, Lawrence W.
Collawn, James F.
Kalinowski, Leszek
Bartoszewski, Rafal
author_sort Janaszak-Jasiecka, Anna
collection PubMed
description The nitric oxide (NO) secreted by vascular endothelium is required for the maintenance of cardiovascular homeostasis. Diminished release of NO generated by endothelial NO synthase contributes to endothelial dysfunction. Hypoxia and ischemia reduce endothelial eNOS expression via posttranscriptional mechanisms that result in NOS3 transcript destabilization. Here, we examine whether microRNAs contribute to this mechanism. We followed the kinetics of hypoxia-induced changes in NOS3 mRNA and eNOS protein levels in primary human umbilical vein endothelial cells (HUVECs). Utilizing in silico predictive protocols to identify potential miRNAs that regulate eNOS expression, we identified miR-200b as a candidate. We established the functional miR-200b target sequence within the NOS3 3′UTR, and demonstrated that manipulation of the miRNA levels during hypoxia using miR-200b mimics and antagomirs regulates eNOS levels, and established that miR-200b physiologically limits eNOS expression during hypoxia. Furthermore, we demonstrated that the specific ablation of the hypoxic induction of miR-200b in HUVECs restored eNOS-driven hypoxic NO release to the normoxic levels. To determine whether miR-200b might be the only miRNA that had this effect, we utilized Next Generation Sequencing (NGS) to follow hypoxia-induced changes in the miRNA levels in HUVECS and found 83 novel hypoxamiRs, with two candidate miRNAs besides miR-200b that could potentially influence eNOS levels. Taken together, the data establish miR-200b-eNOS regulation as a first hypoxamiR-based mechanism that limits NO bioavailability during hypoxia in endothelial cells, and show that hypoxamiRs could become useful therapeutic targets for cardiovascular diseases and other hypoxic-related diseases including various types of cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10456-018-9620-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6208887
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-62088872018-11-09 eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells Janaszak-Jasiecka, Anna Siekierzycka, Anna Bartoszewska, Sylwia Serocki, Marcin Dobrucki, Lawrence W. Collawn, James F. Kalinowski, Leszek Bartoszewski, Rafal Angiogenesis Brief Communication The nitric oxide (NO) secreted by vascular endothelium is required for the maintenance of cardiovascular homeostasis. Diminished release of NO generated by endothelial NO synthase contributes to endothelial dysfunction. Hypoxia and ischemia reduce endothelial eNOS expression via posttranscriptional mechanisms that result in NOS3 transcript destabilization. Here, we examine whether microRNAs contribute to this mechanism. We followed the kinetics of hypoxia-induced changes in NOS3 mRNA and eNOS protein levels in primary human umbilical vein endothelial cells (HUVECs). Utilizing in silico predictive protocols to identify potential miRNAs that regulate eNOS expression, we identified miR-200b as a candidate. We established the functional miR-200b target sequence within the NOS3 3′UTR, and demonstrated that manipulation of the miRNA levels during hypoxia using miR-200b mimics and antagomirs regulates eNOS levels, and established that miR-200b physiologically limits eNOS expression during hypoxia. Furthermore, we demonstrated that the specific ablation of the hypoxic induction of miR-200b in HUVECs restored eNOS-driven hypoxic NO release to the normoxic levels. To determine whether miR-200b might be the only miRNA that had this effect, we utilized Next Generation Sequencing (NGS) to follow hypoxia-induced changes in the miRNA levels in HUVECS and found 83 novel hypoxamiRs, with two candidate miRNAs besides miR-200b that could potentially influence eNOS levels. Taken together, the data establish miR-200b-eNOS regulation as a first hypoxamiR-based mechanism that limits NO bioavailability during hypoxia in endothelial cells, and show that hypoxamiRs could become useful therapeutic targets for cardiovascular diseases and other hypoxic-related diseases including various types of cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10456-018-9620-y) contains supplementary material, which is available to authorized users. Springer Netherlands 2018-05-08 2018 /pmc/articles/PMC6208887/ /pubmed/29737439 http://dx.doi.org/10.1007/s10456-018-9620-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Brief Communication
Janaszak-Jasiecka, Anna
Siekierzycka, Anna
Bartoszewska, Sylwia
Serocki, Marcin
Dobrucki, Lawrence W.
Collawn, James F.
Kalinowski, Leszek
Bartoszewski, Rafal
eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells
title eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells
title_full eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells
title_fullStr eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells
title_full_unstemmed eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells
title_short eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells
title_sort enos expression and no release during hypoxia is inhibited by mir-200b in human endothelial cells
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208887/
https://www.ncbi.nlm.nih.gov/pubmed/29737439
http://dx.doi.org/10.1007/s10456-018-9620-y
work_keys_str_mv AT janaszakjasieckaanna enosexpressionandnoreleaseduringhypoxiaisinhibitedbymir200binhumanendothelialcells
AT siekierzyckaanna enosexpressionandnoreleaseduringhypoxiaisinhibitedbymir200binhumanendothelialcells
AT bartoszewskasylwia enosexpressionandnoreleaseduringhypoxiaisinhibitedbymir200binhumanendothelialcells
AT serockimarcin enosexpressionandnoreleaseduringhypoxiaisinhibitedbymir200binhumanendothelialcells
AT dobruckilawrencew enosexpressionandnoreleaseduringhypoxiaisinhibitedbymir200binhumanendothelialcells
AT collawnjamesf enosexpressionandnoreleaseduringhypoxiaisinhibitedbymir200binhumanendothelialcells
AT kalinowskileszek enosexpressionandnoreleaseduringhypoxiaisinhibitedbymir200binhumanendothelialcells
AT bartoszewskirafal enosexpressionandnoreleaseduringhypoxiaisinhibitedbymir200binhumanendothelialcells